Los Angeles Capital Management LLC Replimune Group, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.2 Billion
- Q4 2024
A detailed history of Los Angeles Capital Management LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 34,547 shares of REPL stock, worth $457,402. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,547
Previous 58,587
41.03%
Holding current value
$457,402
Previous $642,000
34.89%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding REPL
# of Institutions
161Shares Held
74.9MCall Options Held
38.4KPut Options Held
43.7K-
Baker Bros. Advisors LP New York, NY11MShares$146 Million1.48% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$145 Million0.02% of portfolio
-
Redmile Group, LLC San Francisco, CA4.91MShares$64.9 Million4.65% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$62.4 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.97MShares$52.6 Million8.12% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $653M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...